Premium
A rare case of a gabapentin‐induced cardiomyopathy
Author(s) -
Tellor Katie B.,
NgoLam Richard,
Badran Dena,
Armbruster Anastasia L.,
Schwarze Martin W.
Publication year - 2019
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/jcpt.12840
Subject(s) - gabapentin , postherpetic neuralgia , medicine , cardiomyopathy , ejection fraction , stenosis , anesthesia , cardiology , heart failure , surgery , neuropathic pain , pathology , alternative medicine
Summary What is known and objective Gabapentin, a γ‐aminobutyric acid derivative, is used for the treatment of partial onset seizures, postherpetic neuralgia, diabetic neuropathy and a host of other neurological disorders. Case description A 44‐year‐old woman with spinal stenosis was prescribed gabapentin for pain. Two months after initiating therapy, she was diagnosed with a new‐onset non‐ischaemic cardiomyopathy with an ejection fraction of 36% measured on a transthoracic echocardiogram. What is new and Conclusion A patient with suspected gabapentin‐induced cardiomyopathy is reported. However, to date, gabapentin therapy has not been associated with risk of the developing a cardiomyopathy.